Share This Article:

Prognosis of Patients with Acute Coronary Syndromes and Bleeding—The Importance of Routine Use of a Bleeding Risk Score

Abstract Full-Text HTML XML Download Download as PDF (Size:672KB) PP. 327-334
DOI: 10.4236/wjcd.2015.512038    4,296 Downloads   4,762 Views  

ABSTRACT

Introduction: Recent studies showed relation between mortality and bleeding in acute coronary syndromes. Objective: The objective is to analyze the prognosis of patients with acute coronary syndromes with or without in-hospital major and/or minor bleedings. Methods: This was a pro-spective data bank analysis study with 546 patients (39 with bleeding (group I) and 507 without bleeding (group II)) with acute coronary syndromes included between May 2010 and May 2013. Besides, Mehran bleeding risk score was calculated to all patients. The primary endpoint was all causes of in-hospital death and combined events. Comparison between groups was made by Anova and Q-square. Multivariate analysis was determined by logistic regression and was considered significant when p < 0.05. Long-term mortality and combined events were studied using Kaplan-meyer curves. Results: The median Mehran bleeding risk score was 18.78 and 15.11 in groups I and II, respectively. Major bleeding was observed in 4.4%. Significant difference was ob-served between groups I and II in deaths (20.5% vs 2.6%, p = 0.005) and combined events (35.9% vs 11.4%, p < 0.001). The same results were observed in multivariate and long-term analysis. Con-clusions: Almost half of patients with acute coronary syndromes had higher risk of bleeding, and that with major or minor bleedings had greater deaths and combined events.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

de Matos Soeiro, A. , Silva, R. , Bossa, A. , Zullino, C. , de Carvalho Andreucci Torres Leal, T. , de Almeida Soeiro, M. , Serrano Jr., C. and Oliveira Jr., M. (2015) Prognosis of Patients with Acute Coronary Syndromes and Bleeding—The Importance of Routine Use of a Bleeding Risk Score. World Journal of Cardiovascular Diseases, 5, 327-334. doi: 10.4236/wjcd.2015.512038.

References

[1] Nicolau, J.C., Timerman, A., Marin-Neto, J.A., Piegas, L.S., Barbosa, C.J.D.G., Franci, A., et al. (2014) Sociedade Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST. Arquivos Brasileiros de Cardiologia, 102, 1-61.
http://dx.doi.org/10.5935/abc.2014S001
[2] Piegas, L.S., Feitosa, G., Mattos, L.A., Nicolau, J.C., Rossi Neto, J.M., Timerman, A., et al. (2009) Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto agudo do Miocárdio com Supradesnível do Segmento ST. Arquivos Brasileiros de Cardiologia, 93, e179-e264.
[3] Mega, J.L., Braunwald, E., Wiviott, S.D., Bassand, J.P., Bhatt, D.L., Bode, C., et al. (2012) Rivaroxaban in Patients with a Recent Acute Coronary Syndrome. The New England Journal of Medicine, 366, 9-19.
http://dx.doi.org/10.1056/NEJMoa1112277
[4] Wiviott, S., Braunwald, E., McCabe, C., Montalescot, G., Ruzyllo, W., Gottlieb, S., et al. (2007) Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. The New England Journal of Medicine, 357, 2001-2015.
http://dx.doi.org/10.1056/NEJMoa0706482
[5] Eikelboom, J.W., Mehta, S.R., Anand, S.S., Xie, C., Fox, K.A., Yusuf, S., et al. (2006) Adverse Impact of Bleeding on Prognosis in Patients with Acute Coronary Syndromes. Circulation, 114, 774-782.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.612812
[6] Manoukian, S.V., Feit, F., Mehran, R., Voeltz, M.D., Ebrahimi, R., Hamon, M., et al. (2007) Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients with Acute Coronary Syndromes: An Analysis from the ACUITY Trial. Journal of the American College of Cardiology, 49, 1362-1368.
http://dx.doi.org/10.1016/j.jacc.2007.02.027
[7] Rao, S.V., O’Grady, K., Pieper, K.S., Granger, C.B., Newby, L.K., Van de Werf, F., et al. (2005) Impact of Bleeding Severity on Clinical Outcomes among Patients with Acute Coronary Syndromes. American Journal of Cardiology, 96, 1200-1206.
http://dx.doi.org/10.1016/j.amjcard.2005.06.056
[8] Kinnaird, T.D., Stabile, E., Mintz, G.S., Lee, C.W., Canos, D.A., Gevorkian, N., et al. (2003) Incidence, Predictors, and Prognostic Implications of Bleeding and Blood Transfusion Following Percutaneous Coronary Interventions. American Journal of Cardiology, 92, 930-935.
http://dx.doi.org/10.1016/S0002-9149(03)00972-X
[9] Feit, F., Voeltz, M.D., Attubato, M.J., Lincoff, A.M., Chew, D.P., Bittl, J.A., et al. (2007) Predictors and Impact of Major Hemorrhage on Mortality Following Percutaneous Coronary Intervention: An Analysis of the REPLACE-2 Trial. American Journal of Cardiology, 100, 1364-1369.
http://dx.doi.org/10.1016/j.amjcard.2007.06.026
[10] Ndrepepa, G., Berger, P.B., Mehilli, J., Seyfarth, M., Neumann, F.J., Schomig, A., et al. (2008) Periprocedural Bleeding and 1-Year Outcome after Percutaneous Coronary Interventions: Appropriateness of Including Bleeding as a Component of a Quadruple End Point. Journal of the American College of Cardiology, 51, 690-697.
http://dx.doi.org/10.1016/j.jacc.2007.10.040
[11] Mehran, R., Pocock, S.J., Nikolsky, E., Clayton, T., Dangas, G.D., Kirtane, A.J., et al. (2010) A Risk Score to Predict Bleeding in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology, 55, 2556-2566.
http://dx.doi.org/10.1016/j.jacc.2009.09.076
[12] Subherwal, S., Bach, R.G., Chen, A.Y., Gage, B.F., Rao, S.V., Newby, L.K., et al. (2009) Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation, 119, 1873-1882.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.828541
[13] Hamm, C.W., Bassand, J., Agewall, S., Bax, J., Boersma, E., Bueno, H., et al. (2011) ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation. The Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 32, 2999-3054.
http://dx.doi.org/10.1093/eurheartj/ehr236
[14] Jneid, H., Anderson, J.L., Wright, R.S., Adams, C.D., Bridges, C.R., Casey, D.E., et al. (2012) ACCF/AHA Focused Update of the Guideline for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 126, 875-910.
http://dx.doi.org/10.1161/CIR.0b013e318256f1e0
[15] Mehran, R., Rao, S.V., Bahht, D.L., Gibson, M., Caixeta, A., Eikelboom, J., et al. (2011) Standardized Bleeding Definitions for Cardiovascular Clinical Trials. A Consensus Report from the Bleeding Academic Research Consortium. Circulation, 123, 2736-2747.
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.009449
[16] Nikolsky, E., Mehran, R., Dangas, G., Fahy, M., Na, Y., Pocock, S.J., et al. (2007) Development and Validation of a Prognostic Risk Score for Major Bleeding in Patients Undergoing Percutaneous Coronary Intervention via the Femoral Approach. European Heart Journal, 28, 1936-1945.
http://dx.doi.org/10.1093/eurheartj/ehm194
[17] Stone, G.W., Witzenbichler, B., Guagliumi, G., Peruga, J.Z., Brodie, B.R., Dudek, D., et al. (2008) Bivalirudin during Primary PCI in Acute Myocardial Infarction. New England Journal of Medicine, 358, 2218-2230.
http://dx.doi.org/10.1056/NEJMoa0708191
[18] Moscucci, M., Fox, K.A., Cannon, C.P., Klein, W., Lopez-Sendon, J., Montalescot, G., et al. (2003) Predictors of Major Bleeding in Acute Coronary Syndromes: The Global Registry of Acute Coronary Events (GRACE). European Heart Journal, 24, 1815-1823.
http://dx.doi.org/10.1016/S0195-668X(03)00485-8
[19] Fox, C.S., Muntner, P., Chen, A.Y., Alexander, K.P., Roe, M.T., Cannon, C.P., et al. (2010) Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction in Patients with Chronic Kidney Disease: A Report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation, 121, 357-365.
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.865352
[20] Hanna, E.B., Chen, A.Y., Roe, M.T., Funk, M. and Saucedo, J.F. (2011) Characteristics and In-Hospital Outcomes of Patients with Non-ST-Segment Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 4, 1002-1008.
http://dx.doi.org/10.1016/j.jcin.2011.05.022
[21] Yusuf, S., Zhao, F., Mehta, S.R., Chrolavicius, S., Tognoni, G. and Fox, K.K. (2001) Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. New England Journal of Medicine, 345, 494-502.
http://dx.doi.org/10.1056/NEJMoa010746
[22] Wang, T.Y., Xiao, L., Alexander, K.P., Rao, S.V., Kosiborod, M.N., Rumsfeld, J.S., et al. (2008) Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-Hospital Bleeding. Circulation, 118, 2139- 2145.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.787143
[23] Dietrich, K.A., Conrad, S.A., Hebert, C.A., Levy, G.L. and Romero, M.D. (1990) Cardiovascular and Metabolic Response to Red Blood Cell Transfusion in Critically Ill Volume-Resuscitated Nonsurgical Patients. Critical Care Medicine, 18, 940-944.
http://dx.doi.org/10.1097/00003246-199009000-00007
[24] Rao, S.V., Jollis, J.G., Harrington, R.A., Granger, C.B., Newby, L.K., Armstrong, P.W., et al. (2004) Relationship of Blood Transfusion and Clinical Outcomes in Patients with Acute Coronary Syndromes. JAMA, 292, 1555-1562.
http://dx.doi.org/10.1001/jama.292.13.1555
[25] Smith, K.J., Bleyer, A.J., Little, W.C. and Sane, D.C. (2003) The Cardiovascular Effects of Erythropoietin. Cardiovascular Research, 59, 538-548.
http://dx.doi.org/10.1016/S0008-6363(03)00468-1
[26] Mehran, R., Pocock, S.J., Stone, G.W., Clayton, T.C., Dangas, G.D., Feit, F., et al. (2009) Associations of Major Bleeding and Myocardial Infarction with the Incidence and Timing of Mortality in Patients Presenting with Non-ST-Elevation Acute Coronary Syndromes: A Risk Model from the ACUITY Trial. European Heart Journal, 30, 1457- 1466.
http://dx.doi.org/10.1093/eurheartj/ehp110
[27] Yusuf, S., Mehta, S.R., Chrolavicius, S., Afzal, R., Pogue, J., Granger, C.B., et al. (2006) Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. New England Journal of Medicine, 354, 1464-1476.
http://dx.doi.org/10.1056/NEJMoa055443
[28] Steg, P.G., Jolly, S.S., Mehta, S.R., Afzal, R., Xavier, D., Rupprecht, H.J., et al. (2010) Low-Dose vs. Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated with Fondaparinux: The FUTURA/OASIS-8 Randomized Trial. JAMA, 304, 1339-1349.
http://dx.doi.org/10.1001/jama.2010.1320
[29] Alexander, K.P., Chen, A.Y., Roe, M.T., Newby, L.K., Gibson, C.M., Allen-LaPointe, N.M., et al. (2005) Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA, 294, 3108-3116.
http://dx.doi.org/10.1001/jama.294.24.3108
[30] Ariza-Solé, A., Salazar-Mendiguchía, J., Lorente, V., Sánchez-Salado, J.C., Romaguera, R., Ferreiro, J.L., et al. (2015) Predictive Ability of Bleeding Risk Scores in the Routine Clinical Practice. European Heart Journal: Acute Cardiovascular Care, 4, 3205-3210.
[31] Becker, R.C., Bassand, J.P., Budaj, A., Wojdyla, D.M., James, S.K., Cornel, J.H., et al. (2011) Bleeding Complications with the P2Y12 Receptor Antagonists Clopidogrel and Ticagrelor in the PLATelet Inhibition and Patient Outcomes (PLATO) Trial. European Heart Journal, 32, 2933-2944.
http://dx.doi.org/10.1093/eurheartj/ehr422
[32] Ariza-Solé, A., Salazar-Mendiguchía, J., Lorente, V., Sánchez-Salado, J.C., Romaguera, R., Ferreiro, J.L., et al. (2015) Predictive Ability of Bleeding Risk Scores in the Routine Clinical Practice. European Heart Journal: Acute Cardiovascular Care, 4, 205-210.
http://dx.doi.org/10.1177/2048872614538405
[33] Hamon, M., Rasmussen, L.H., Manoukian, S.V., Cequier, A., Lincoff, M.A., Rupprecht, H.J., et al. (2009) Choice of Arterial Access Site and Outcomes in Patients with Acute Coronary Syndromes Managed with an Early Invasive Strategy: The ACUITY Trial. EuroIntervention, 5, 115-120.
http://dx.doi.org/10.4244/EIJV5I1A18
[34] Jolly, S.S., Amlani, S., Hamon, M., Yusuf, S. and Mehta, S.R. (2009) Radial versus Femoral Access for Coronary Angiography or Intervention and the Impact on Major Bleeding and Ischemic Events: A Systematic Review and Meta-Analysis of Randomized Trials. American Heart Journal, 157, 132-140.
http://dx.doi.org/10.1016/j.ahj.2008.08.023
[35] Sanborn, T.A., Ebrahimi, R., Manoukian, S.V., McLaurin, B.T., Cox, D.A., Feit, F., et al. (2010) Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial. Circulation: Cardiovascular Interventions, 3, 57-62.
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.109.896704

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.